Long non-coding RNAs as the critical factors during tumor progressions among Iranian population: an overview

Rahmani, Zahra; Mojarrad, Majid; Moghbeli, Meysam

doi:10.1186/s13578-020-0373-0

Cell & Bioscience

Table 1 All of the long non coding RNAs involved in tumor progressions among Iranian patients

From: Long non-coding RNAs as the critical factors during tumor progressions among Iranian population: an overview

Study (et al.)	Year	Type	Gene	Population	Results
Shahryari [37]	2014	ESCC	SOX2OT	36 N/T^a	Over expression
Rezaei [45]	2016	Esophageal, ovarian, cervical, breast, sarcoma, colon, and melanoma	LINC-ROR	27 N/T	Esophageal, ovarian, and cervical cancers had over expressions while breast, sarcoma, colon, and melanoma had under expressions
Sahebi [49]	2016	ESCC	LINC-ROR	30 N/T	Over expression
Rahimnia [51]	2018	ESCC	lnc-POU3F3	32 patients 32 controls	Over expression
Razavi [56]	2019	ESCC	lnc-PCAT-1	75 N/T	Over expression
Bayat [58]	2018	Prostate	Prcat17.3, Prcat38, Cat2184.4	30 N/T	Prcat17.3 and Prcat38 over expressions and Cat2184.4 under expression
Taheri [60]	2017	Prostate	HOTAIR	128 patients 250 controls	Polymorphism was correlated with tumor progression
Taheri [64]	2017	Prostate	ANRIL	125 patients 220 controls	Polymorphism was correlated with tumor progression
Sattarifard [66]	2017	Prostate	PRNCR1	178 patients 180 BPH^b	Polymorphism was correlated with tumor progression
Yazarlou [83]	2018	Bladder	LINC00355, UCA1-203, MALAT1, and UCA1-201	59 patients 24 controls	LINC00355, UCA1-203, and MALAT1 over expressions. UCA1-201 under expression
Farhangian [88]	2018	Gastric	SOX2OT	33 N/T	Under expression
Hajjari [90]	2013	Gastric	HOTAIR	31 N/T	Over expression
Emadi-Andani [91]	2014	Gastric	HOTAIR	60 N/T	Over expression
Baratieh [97]	2017	Gastric	PlncRNA-1 and TUG1	70 N/T	Over expression
Aminian [103]	2019	Gastric	GAS5	130 patients 230 controls	Polymorphism was correlated with tumor progression
Kangarlouei [106]	2019	Gastric	ANRIL and ANRASSF1	39 N/T	Over expression
Iranpour [111]	2016	Breast	SOX2OT, PTPRG-AS1, ANRASSF1, and ANRIL	38 N/T	Over expression
Hassanzarei [114]	2017	Breast	HOTAIR	220 patients 231 controls	Polymorphism was correlated with tumor progression
Hassanzarei [118]	2017	Breast	H19	230 patients 240 controls	Polymorphism was correlated with tumor progression
Safari [119]	2019	Breast	H19	111 patients 130 controls	Polymorphism was correlated with tumor progression
Abdollahzadeh [120]	2019	Breast	H19	150 patients 100 controls	Polymorphism was correlated with tumor progression
Arshi [130]	2018	Breast	MALAT1, SRA, NEAT1, and GAS5	23 patients 15 controls	MALAT1, SRA, and NEAT1 over expressions. GAS5 under expression
Soleimanpour [135]	2018	Breast	PRNCR1	30 N/T	Over expression
Ravanbakhsh [138]	2019	Breast	lncUSMycN	52 N/T	Over expression
Rezanejad Bardaji [140]	2018	Colorectal	ZEB1-AS1	32 N/T	Over expression
Kazemzadeh [143]	2017	Colorectal	LOC100287225	30 N/T	Under expression
Kazemzadeh [142]	2016	Colorectal	LOC100287225	39 N/T	Under expression
Rezanejad bardaji [144]	2018	Colorectal	VIM-AS1	35 N/T	Over expression
Hashemi [146]	2016	ALL	lnc-LAMC2-1:1	110 patients 120 controls	Polymorphism was correlated with tumor progression
Esfandi [150]	2018	Lung	OIP5-AS	32 N/T	Under expression

^aTumor tissues and normal margins
^bBenign prostatic hyperplasia

Back to article page

ISSN: 2045-3701

Contact us

Submission enquiries: Access here and click Contact Us
General enquiries: info@biomedcentral.com